©Author(s) (or their employer(s)) 2026.
World J Stem Cells. Feb 26, 2026; 18(2): 114032
Published online Feb 26, 2026. doi: 10.4252/wjsc.v18.i2.114032
Published online Feb 26, 2026. doi: 10.4252/wjsc.v18.i2.114032
Figure 1 Supplementation with epiregulin enhanced the migration, chemotaxis, and osteogenic differentiation of mouse bone marrow stem cells under inflammatory conditions.
A and B: Scratch-simulated wound migration assay results (n = 3, one-way analysis of variance [ANOVA]). Scale bar: 500 μm; C and D: Transwell chemotaxis assay results (n = 3, one-way ANOVA). Scale bar: 50 μm; E: Alizarin Red staining; F: Expression of osterix (OSX) and osteocalcin (OCN) was revealed in mouse bone marrow stem cells that were cultured in the inflammatory condition by western blotting. Error bars represent standard deviation. aP ≤ 0.05; bP ≤ 0.01. EREG: Epiregulin; TNF: Tumor necrosis factor.
- Citation: Zhao YC, Li GY, Chen S, Wang YL, Feng JY, Cao Y. Epiregulin enhances periodontal tissue regeneration by promoting bone marrow mesenchymal stem cell functions under inflammatory niches. World J Stem Cells 2026; 18(2): 114032
- URL: https://www.wjgnet.com/1948-0210/full/v18/i2/114032.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v18.i2.114032